Clinical Trial Update: Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea [Phase 3]

View source ↗

Summary

A randomized, double-blind, placebo-controlled Phase 3 trial evaluated treatment for moderate to severe facial erythema due to rosacea; results have been posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Snippet

Sponsor: Actavis Inc. | Conditions: Rosacea | Phase 3 | Status: COMPLETED | Results posted: 2020-01-14